Acomhal Research, Inc.

Acomhal Research, Inc. is a biotech startup focused on developing therapeutic solutions to prevent tumor recurrence and metastasis. Founded by Dr. Samy Y. Lamouille, the company leverages his extensive experience in cancer research and biotechnology. Operating within the biotech sector, Acomhal Research serves the medical and healthcare markets, particularly targeting oncology professionals and institutions. The business model revolves around research and development of novel cancer treatments, with funding sourced from grants and seed investments. Acomhal's revenue generation is primarily through partnerships, licensing agreements, and potential commercialization of its therapeutic solutions. The company was recognized by the Association of Public and Land-grant Universities for its innovative approach, highlighting its commitment to advancing cancer treatment.

Keywords: cancer, biotech, tumor, metastasis, therapeutic, oncology, research, treatment, healthcare, prevention.